STARPAX BIOPHARMA ANNOUNCES THE APPOINTMENT OF ANDRÉANNE CYR AS VICE PRESIDENT FINANCE & ADMINISTRATION
MONTREAL, Dec. 12, 2023 /PRNewswire/ - Starpax Biopharma Inc., a biopharmaceutical company developing a groundbreaking cancer treatment platform technology ("Starpax"), is pleased to announce the promotion of Mrs. Andréanne Cyr to Vice President Finance.
- MONTREAL, Dec. 12, 2023 /PRNewswire/ - Starpax Biopharma Inc., a biopharmaceutical company developing a groundbreaking cancer treatment platform technology ("Starpax"), is pleased to announce the promotion of Mrs. Andréanne Cyr to Vice President Finance.
- Andréanne Cyr is a Certified Public Accountant (CPA) with over 10 years of professional experience in finance, holding positions as auditor and director of finance in various industries.
- In a parallel development, Starpax announces the appointment of Mr. Fred Heinzelmann as Senior Advisor - Finance.
- Michael Gareau, founding president of Starpax Biopharma, stated " These strategic nominations were planned with our current CFO, Jean François Pruneau, who during his two-year mandate completed the setting up and structuration of Starpax' corporate finance function.